Trevi Therapeutics
TRVI
#7271
Rank
NZ$0.64 B
Marketcap
$7.18
Share price
0.00%
Change (1 day)
225.31%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.51

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.55. In 2022 the company made an earnings per share (EPS) of -$0.99 an increase over its 2021 EPS that were of -$2.66.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.51-48.19%
2022-$0.99-62.67%
2021-$2.66-17.29%
2020-$3.2218.17%
2019-$2.72-46.21%
2018-$5.06